"10.1371_journal.pone.0052512","plos one","2013-01-11T00:00:00Z","Elena Stacy Mazzone; Marika Pane; Maria Pia Sormani; Roberta Scalise; Angela Berardinelli; Sonia Messina; Yvan Torrente; Adele D’Amico; Luca Doglio; Emanuela Viggiano; Paola D’Ambrosio; Filippo Cavallaro; Silvia Frosini; Luca Bello; Serena Bonfiglio; Roberto De Sanctis; Enrica Rolle; Flaviana Bianco; Francesca Magri; Francesca Rossi; Gessica Vasco; GianLuca Vita; Maria Chiara Motta; Maria Alice Donati; Michele Sacchini; Tiziana Mongini; Antonella Pini; Roberta Battini; Elena Pegoraro; Stefano Previtali; Sara Napolitano; Claudio Bruno; Luisa Politano; Giacomo Pietro Comi; Enrico Bertini; Eugenio Mercuri","Department of Paediatric Neurology, Catholic University, Rome, Italy; Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa, Italy; Child Neurology and Psychiatry Unit, C. Mondino Foundation, Pavia, Italy; Department of Neurosciences, Psychiatry and Anaesthesiology, University of Messina, Messina, Italy; Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Neurology Unit, Ca Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Laboratory Medicine, Unit of Molecular Medicine, Bambino Gesù Hospital, Rome, Italy; Neuromuscular Disease Unit, G. Gaslini Institute, Genoa, Italy; Dipartimento di Medicina Sperimentale, Seconda Università di Napoli, Naples Italy; Department of Developmental Neuroscience, Stella Maris Institute, University of Pisa, Pisa, Italy; Department of Neurosciences, University of Padua, Padua, Italy; Child Neurology and Psychiatry Unit, Maggiore Hospital, Bologna, Italy; Neuromuscular Center, SG. Battista Hospital, University of Turin, Turin, Italy; Metabolic and Neuromuscular Unit, Meyer Hospital, Florence, Italy; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy","Conceived and designed the experiments: EM MP CB EB EM AD SM FB EP. Performed the experiments: EM LD FC RD SF FC LB PDA EV MS MCM GLV FR ER SB SN. Analyzed the data: EM MP MPS RS SM EM AB YT CB GC FM SP LP RB AP AD EP GV. Contributed reagents/materials/analysis tools: EM LD FC RD SF FC GV TM MAD. Wrote the paper: EM MP EB EM.","E. Mazzone and Dr. Pane report no disclosures. Dr. Sormani serves on a scientific advisory board for Biogen Idec.; has received funding for travel or speaker honoraria from Merck Serono; serves as consultant for Merck Serono, Actelion Pharmaceuticals Lts. Biogen Idec, and Synthon; and serves on the speakers bureaus of Teva Pharmaceutical Industries Ltd., Merck Serono, and Biogen Idec. Dr. Scalise, Dr. Berardinelli, Dr Messina, Dr. Torrente, Dr. DAmico, Dr. Doglio, Dr. Viggiano, Dr. DAmbrosio, F. Cavallaro, S. Frosini, Dr. Bello, Dr. Bonfiglio, R. De Sanctis, E. Rolle, Dr. Bianco, Dr. Magri, F. Rossi, and Dr. Vasco report no disclosures. Dr. Vita serves as an Associate Editor for Neurological Sciences. M.C. Motta, Dr. Donati and Dr. Sacchini report no disclosures. Dr. Mongini has received funding for travel from Genzyme Corporation; and has received research support from AIFA (Italian Government Drug Agency) and Telethon Italy. Dr. Pini and Dr. Battini report no disclosures. Dr. Pegoraro has served on a scientific advisory board for BioMarin Pharmaceutical Inc.; has received funding for travel from Genzyme Corporation; and has received speaker honoraria from MedaPharma; and receives research support from Wellstone and Telethon Italy. Dr. Previtali, Dr. Bruno and Dr. Politano report no disclosures. Dr. Comi is site PI for the PTC extension study of Ataluren in DMD, for the TROPHOS clinical trial on SMA and for the GSK study on exon skipping; receives research support from Telethon Italy and SMA Europe. Dr. Bertini is site PI for the PTC extension study of Ataluren in DMD, for the TROPHOS clinical trial on SMA and for the GSK study on exon skipping. He also receives funds from the Italian Telethon, the Italian Ministry of Health and SMA Europe for observational studies on outcome measures. Dr. Mercuri is site PI for the PTC extension study of Ataluren in DMD, for the TROPHOS clinical trial on SMA and for the GSK study on exon skipping. He also receives funds from the Italian Telethon and SMA Europe. He has acted as advisory board for Shire and PTC Therapeutics, Inc, Prosensa. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Elena Stacy Mazzone","ESM",36,TRUE,8,15,17,3,TRUE,TRUE,FALSE,0,NA,FALSE
